Market understanding in Parkinson’s disease
Our client was preparing to launch a treatment for Parkinson’s disease.
Delivering successful solutions for our clients.
Our client was preparing to launch a treatment for Parkinson’s disease.
We re-launched the team with a set of skilled, motivated and experienced hospital representatives in this highly specialised area.
20% increase in market share for three mature brands versus when Ashfield started in 2014
Within four weeks, Ashfield improved the service level dramatically with 80% of calls being taken within 20 seconds.
Ashfield's patient support programme (PSP) provides care, information and support for patients living with a rare and progressive respiratory disease.